What Painkiller Is Best for Eye Pain?

No single painkiller works best for every type of eye pain, because eye pain has wildly different causes and the right treatment hinges on what is actually wrong. A scratched cornea, a pressure spike from glaucoma, chronic dry eye, and post-surgical soreness all produce pain through different mechanisms and respond to different drugs. What is consistent is that the eye is the most sensitive tissue in the body, which means pain tends to be intense but also that treatment choices carry real consequences for healing and vision.

Why Eye Pain Is Different From Other Pain

The cornea is packed with nerve fibers more densely than any other tissue you have. It is innervated exclusively by pain-sensing and temperature-sensing nerve fibers that connect to the trigeminal nerve, the same nerve responsible for severe facial pain conditions like trigeminal neuralgia.¹ That density is why even a tiny eyelash or a speck of dust can produce sharp, disproportionate pain. It also means the cornea heals differently when its nerve supply is disrupted, which is a central concern when choosing painkillers: some drugs that numb the surface effectively can slow healing or damage it outright.

Because of this, the approach to eye pain is more cautious than pain elsewhere in the body. You would not hesitate to ice a sore knee or take a strong anti-inflammatory for a pulled muscle. With the eye, clinicians weigh the risk that a painkiller might mask a worsening problem or directly harm the corneal surface. That tradeoff shapes every recommendation below.

Over-the-Counter Oral Painkillers

For mild to moderate eye pain from causes like a minor scratch, mild inflammation, or general soreness after an eye exam, oral painkillers from the medicine cabinet are the safest first step. Ibuprofen and similar anti-inflammatory drugs reduce both pain and the inflammation that often drives it. Acetaminophen handles pain without addressing inflammation, making it useful when inflammation is not the main problem or when you cannot take anti-inflammatories.

Neither drug will do much for severe eye pain from conditions like acute glaucoma or a deep corneal ulcer, but for everyday eye discomfort they are the most straightforward option with the fewest risks to the eye itself. Eye doctors often recommend oral ibuprofen as a baseline, adding other treatments on top as needed rather than jumping straight to something stronger.

Topical Anesthetic Drops and the Safety Debate

Numbing drops like tetracaine and proparacaine are the drugs eye doctors use to make your eye comfortable during an exam or procedure. They work almost instantly by blocking the pain-sensing nerves right at the corneal surface. The longstanding advice has been that patients should never take these drops home because repeated use can severely damage the cornea. That advice is now partially being challenged by newer research, though with important caveats.

The concern about topical anesthetics is well-documented. Repeated or prolonged use can poison the cells that make up the cornea’s surface and deeper layers, leading to swelling, tissue breakdown, and in severe cases a condition called toxic keratitis that can mimic serious infections and threaten vision.² Case reports describe patients who used dilute anesthetic drops after laser eye surgery and developed ring-shaped corneal damage along with permanent loss of the cells lining the inside of the cornea.³

However, several clinical trials have found that short-term, controlled use of tetracaine for corneal abrasions appears safe. One randomized trial found that short-term topical tetracaine was highly effective for pain from corneal abrasions, was associated with less opioid use compared to placebo, and showed no safety concerns.⁴ Another trial specifically tested 24 hours of tetracaine use and found it safe, with patients rating it significantly more effective than saline.⁵ An observational study of emergency department patients sent home with a 24-hour supply found no serious complications, though the authors noted that confidence intervals were wide and some increased risks were seen for non-simple abrasions.⁶

The takeaway is nuanced. For a simple corneal scratch, a doctor-supervised short course of numbing drops may be reasonable. But self-medicating with anesthetic drops, using them for more than a day or two, or using them for conditions other than simple abrasions remains dangerous. The damage from misuse can be permanent and vision-threatening.

Topical NSAID Eye Drops

Anti-inflammatory eye drops like ketorolac (Acular) and diclofenac are prescription medications that reduce pain and inflammation directly on the eye’s surface without the numbing effect of anesthetics. They are commonly prescribed after eye surgeries like cataract removal and laser procedures. For corneal abrasions, one study found that combining a topical NSAID with a bandage contact lens produced a significant decrease in pain compared to either alone.⁷

These drops are not risk-free, though. The most serious known side effect is corneal melt, where the cornea essentially breaks down. This complication has been reported with nearly all approved topical NSAIDs and occurs most often in people whose corneas are already vulnerable from surgery, diabetes, or autoimmune conditions.⁸ One case report described a patient who developed corneal melt and perforation just five days after starting routine NSAID drops following cataract surgery, ultimately losing useful vision in that eye despite multiple surgical interventions.⁹ Corneal melt remains rare, but the consequences are severe enough that topical NSAIDs should only be used under an eye care provider’s supervision, and people with compromised corneas or autoimmune disease need to be particularly cautious.

Cycloplegic Drops for Deeper Eye Pain

When pain comes from inflammation inside the eye rather than on its surface, a different class of drops can help. Cycloplegic drops like homatropine and cyclopentolate temporarily paralyze the muscle that controls the pupil and the focusing muscle inside the eye. This prevents painful spasms of these muscles, which are a major source of discomfort in conditions like iritis (inflammation of the iris) and after certain injuries.

A systematic review and meta-analysis found that homatropine and cyclopentolate produced significant reductions in pain after two days of use.¹⁰ These drops blur your vision and make you extremely light-sensitive while they are active, so they are not something you would use casually. But for the right type of pain, particularly the deep, aching discomfort from internal eye inflammation, they address the actual source of the problem rather than just masking it.

Post-Surgical Pain and Prescription Opioids

Eye surgeries like photorefractive keratectomy (PRK), where the corneal surface is intentionally reshaped, can produce significant pain for the first few days. This is one of the few contexts where prescription-strength painkillers are routinely considered for eye-related pain. A randomized trial found that adding codeine with acetaminophen to standard post-PRK care produced clinically meaningful pain reductions compared to placebo at one, 24, 48, and 72 hours after surgery.¹¹

A follow-up question many patients have is whether they need the strongest possible opioid for this pain. A separate trial compared codeine/acetaminophen to oxycodone/acetaminophen after PRK and found no clinical difference in pain control or long-term visual outcomes between the two. The researchers concluded that treating post-surgical eye pain with the milder opioid was just as effective and carried a lower risk of misuse and dependence.¹² This finding matters beyond eye surgery: when opioids are needed for eye pain at all, starting with a milder one rather than a stronger one makes sense.

Dry Eye Pain and Anti-Inflammatory Approaches

Dry eye is probably the single most common cause of chronic eye discomfort, and it is one where the word “painkiller” can be misleading. The pain of dry eye is driven largely by ongoing inflammation of the cornea and conjunctiva, so the most effective approach targets that inflammation rather than just dulling the pain signal.¹³

Anti-inflammatory treatments for dry eye span a wide range. Artificial tears and lubricants are the foundation, reducing friction and providing a temporary barrier. When those are not enough, prescription anti-inflammatory drugs come into play. Topical corticosteroids like fluorometholone or loteprednol can be used in short bursts to break a cycle of inflammation. One clinical study comparing corticosteroids to topical NSAIDs in dry eye patients found that the corticosteroid group had significantly lower symptom scores and fewer signs of surface damage at 15 and 30 days.¹⁴ Non-steroidal immunomodulators like cyclosporine (Restasis) and lifitegrast (Xiidra) work more slowly but are designed for long-term use. Anti-inflammatory agents have shown clear success in moderate to severe dry eye compared to lubricants alone.¹⁵

Taking ibuprofen by mouth for dry eye pain works in the short term, but it does nothing about the underlying inflammatory process on the eye’s surface and can even worsen dryness in some people. If your eye pain is from dry eye, treating the dryness and inflammation is the actual “painkiller.”

Chronic and Neuropathic Eye Pain

Some people develop persistent eye pain that does not match any visible problem on the eye’s surface. The cornea looks normal under examination, tears are adequate, pressure is fine, and yet the pain continues. This pattern, sometimes called neuropathic ocular pain, occurs when the pain-sensing nerves themselves become dysfunctional, firing pain signals without an ongoing stimulus. It can develop after eye surgery, a bad bout of dry eye, or sometimes without a clear trigger.

Standard painkillers and eye drops tend to do very little for neuropathic ocular pain. Treatment instead borrows from the approach used for nerve pain elsewhere in the body. Gabapentin and other anticonvulsant medications have been used with success. Certain antidepressants, including both SSRIs and older tricyclic antidepressants, can also be effective for this kind of pain, though tricyclics come with more side effects.¹⁶ For cases where the surface of the eye is contributing, aggressive lubrication and autologous serum tears (made from the patient’s own blood) can help calm things down alongside the nerve-targeting medications.

Recognizing neuropathic eye pain matters because patients with this condition often cycle through multiple eye drops and painkillers without relief. If your eye hurts persistently and your eye doctor cannot find a surface problem, asking about neuropathic pain and nerve-targeting medications is worthwhile.

Non-Drug Approaches That Actually Help

Several non-medication strategies can meaningfully reduce eye pain, particularly when combined with appropriate drugs. Bandage contact lenses are thin, soft lenses placed over a damaged cornea to protect it from the blinking eyelid, which is one of the main sources of pain after a corneal injury or surgery. As noted above, combining a bandage lens with a topical NSAID outperformed either treatment alone for corneal abrasion pain.

Cold therapy after eye surgery is another option with evidence behind it. A study of patients recovering from surface laser eye surgery found that applying a cold patch significantly reduced pain scores at 8, 16, and 24 hours compared to standard care, and patients in the cold patch group used fewer painkillers overall.¹⁷ A cold washcloth or gel pack over closed eyes is a simple, zero-risk way to take the edge off many kinds of eye discomfort.

Interestingly, one popular folk remedy does not hold up under scrutiny. Many people refrigerate their artificial tears, believing the cold drops feel more soothing. A clinical trial testing this found no comfort advantage to refrigerated drops compared to room-temperature drops for mild to moderate dry eye.¹⁸ Cooling the drops does not hurt anything, but do not expect it to make a noticeable difference.

Getting the Most Out of Eye Drops

However effective an eye drop is in theory, much of it drains straight down the tear duct and into your nose and throat within seconds of instillation. This reduces the drug’s contact time with the eye and increases systemic absorption, which is why some people taste their eye drops or experience side effects that seem unrelated to the eye.

Two simple techniques improve this. The first is nasolacrimal occlusion: after putting in a drop, press a finger gently against the inner corner of your eye (near the nose) for one to two minutes. This blocks the drainage pathway and keeps more of the drug on the eye. The second is simply keeping your eyelids closed for the same period. A review of the literature found that both techniques improve how much medication penetrates the eye while reducing how much enters the bloodstream.¹⁹ The nasolacrimal occlusion technique is effective but hard for many patients to do correctly on their own.²⁰ Simply closing your eyes after putting in a drop is the more practical version for most people.

Acute Glaucoma and Pain That Signals an Emergency

Some eye pain is not a comfort problem but an emergency. Acute angle-closure glaucoma causes severe eye pain, headache, nausea, and blurred vision when the drainage angle inside the eye suddenly closes and pressure spikes. No over-the-counter painkiller will address this, and delaying treatment risks permanent vision loss. The treatment is to lower the pressure itself, not to manage the pain as a separate issue. A randomized trial comparing laser treatment to conventional medications for acute angle-closure found that the laser group had lower eye pressure within the first hour, though both approaches equalized by two hours.²¹ The pain resolves once the pressure drops.

Other red flags that mean eye pain needs urgent evaluation rather than home treatment include sudden vision loss or significant blurring, pain after a penetrating injury or chemical exposure, a white spot on the cornea suggesting an ulcer or infection, and pain accompanied by fever or a rash near the eye (which can indicate shingles). In these situations, reaching for a painkiller is fine for comfort, but it is not a substitute for getting to an eye doctor or emergency room.

Sex Differences in Eye Pain Sensitivity

An underappreciated factor in eye pain is that corneal sensitivity differs between men and women, which can affect how much pain is experienced and how aggressively it needs to be treated. A study measuring corneal sensitivity across different regions of the eye found significantly higher sensitivity in men compared to women in most tested areas.²² Meanwhile, estrogen appears to play a direct role in maintaining corneal nerve function and tear production. Animal research has shown that estrogen deficiency leads to decreased tear formation, reduced corneal sensitivity, and surface damage, while estrogen replacement reverses these changes and modulates how the cornea responds to pain stimuli.²³

This helps explain why dry eye disease and the discomfort that comes with it are disproportionately common in postmenopausal women. Hormone changes alter the corneal nerves and tear film simultaneously, creating both the condition and the pain. For these patients, treating the hormonal component (when appropriate) can address the root cause in a way that no painkiller will.

Emerging Research on Pain Receptors in the Eye

One of the more promising directions in eye pain research focuses on a receptor called TRPA1, which sits on corneal nerve endings and responds to chemical irritants, mechanical pressure, and temperature changes. In a mouse model of dry eye disease, blocking TRPA1 with a topical drug reversed the mechanical hypersensitivity and discomfort associated with the condition. The blocker also promoted corneal nerve regeneration and reduced inflammatory markers in the cornea, suggesting it could tackle both the pain and the underlying nerve damage at once.²⁴

This is still early-stage work in animals, but it points toward a future where eye pain treatments could be more targeted, calming the specific receptors responsible for pain without the tissue-damaging effects of topical anesthetics or the non-specific suppression of anti-inflammatory drugs. Current options for eye pain all involve tradeoffs. A therapy that selectively dials down corneal pain signaling while supporting nerve health would be a genuine advance, particularly for the millions of people with chronic dry eye pain who cycle through treatments without lasting relief.